Which Strategy Is More Effective for the Treatment of Cardiovascular Disease : High-Dose Angiotensin II Type 1 Receptor Antagonist Monotherapy or Combination Therapy?
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Works matching IS 11753277 AND DT 2008 AND VI 8 AND IP 2
Results: 9
1
2
Long-Term Safety and Efficacy of a Combination of Niacin Extended Release and Simvastatin in Patients with Dyslipidemia : The OCEANS Study.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
3
Comparison of Efficacy of Low- (80 mg/day) and High- (160-320 mg/day) Dose Valsartan in the Prevention of In-Stent Restenosis after Implantation of Bare-Metal Stents in Type B2/C Coronary Artery Lesions.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
4
Rosuvastatin: A Review of its Effect on Atherosclerosis.
- Published in:
- American Journal of Cardiovascular Drugs, 2008, v. 8, n. 2, p. 127, doi. 10.1007/BF03256589
- By:
- Publication type:
- Article
5
Aspirin and Platelet Adenosine Diphosphate Receptor Antagonists in Acute Coronary Syndromes and Percutaneous Coronary Intervention: Role in Therapy and Strategies to Overcome Resistance.
- Published in:
- American Journal of Cardiovascular Drugs, 2008, v. 8, n. 2, p. 91, doi. 10.1007/BF03256587
- By:
- Publication type:
- Article
6
Which Strategy Is More Effective for the Treatment of Cardiovascular Disease: High-Dose Angiotensin II Type 1 Receptor Antagonist Monotherapy or Combination Therapy?
- Published in:
- American Journal of Cardiovascular Drugs, 2008, v. 8, n. 2, p. 88, doi. 10.1007/BF03256586
- By:
- Publication type:
- Article
7
Comparison of Efficacy of Low- (80 mg/day) and High- (160-320 mg/day) Dose Valsartan in the Prevention of In-Stent Restenosis after Implantation of Bare-Metal Stents in Type B2/C Coronary Artery Lesions.
- Published in:
- American Journal of Cardiovascular Drugs, 2008, v. 8, n. 2, p. 83, doi. 10.1007/BF03256585
- By:
- Publication type:
- Article
8
Long-Term Safety and Efficacy of a Combination of Niacin Extended Release and Simvastatin in Patients with Dyslipidemia: The OCEANS Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2008, v. 8, n. 2, p. 69, doi. 10.2165/00129784-200808020-00001
- By:
- Publication type:
- Article
9
Fondaparinux Sodium: A Review of its Use in the Management of Acute Coronary Syndromes.
- Published in:
- American Journal of Cardiovascular Drugs, 2008, v. 8, n. 2, p. 113, doi. 10.1007/BF03256588
- By:
- Publication type:
- Article